93 related articles for article (PubMed ID: 11350210)
1. Regulation of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced tumor promotion by 17 beta-estradiol in female Sprague--Dawley rats.
Wyde ME; Eldridge SR; Lucier GW; Walker NJ
Toxicol Appl Pharmacol; 2001 May; 173(1):7-17. PubMed ID: 11350210
[TBL] [Abstract][Full Text] [Related]
2. Ovarian hormones enhance 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated increases in cell proliferation and preneoplastic foci in a two-stage model for rat hepatocarcinogenesis.
Lucier GW; Tritscher A; Goldsworthy T; Foley J; Clark G; Goldstein J; Maronpot R
Cancer Res; 1991 Mar; 51(5):1391-7. PubMed ID: 1671757
[TBL] [Abstract][Full Text] [Related]
3. Promotion of altered hepatic foci by 2,3,7,8-tetrachlorodibenzo-p-dioxin and 17beta-estradiol in male Sprague-Dawley rats.
Wyde ME; Cambre T; Lebetkin M; Eldridge SR; Walker NJ
Toxicol Sci; 2002 Aug; 68(2):295-303. PubMed ID: 12151625
[TBL] [Abstract][Full Text] [Related]
4. Toxicity of chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin in diethylnitrosamine-initiated ovariectomized rats implanted with subcutaneous 17 beta-estradiol pellets.
Wyde ME; Seely J; Lucier GW; Walker NJ
Toxicol Sci; 2000 Apr; 54(2):493-9. PubMed ID: 10774832
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the promotion of altered hepatic foci by 2,3,7,8-tetrachlorodibenzo-p-dioxin in the female rat.
Dragan YP; Xu XH; Goldsworthy TL; Campbell HA; Maronpot RR; Pitot HC
Carcinogenesis; 1992 Aug; 13(8):1389-95. PubMed ID: 1354083
[TBL] [Abstract][Full Text] [Related]
6. Induction of hepatic 8-oxo-deoxyguanosine adducts by 2,3,7,8-tetrachlorodibenzo-p-dioxin in Sprague-Dawley rats is female-specific and estrogen-dependent.
Wyde ME; Wong VA; Kim AH; Lucier GW; Walker NJ
Chem Res Toxicol; 2001 Jul; 14(7):849-55. PubMed ID: 11453731
[TBL] [Abstract][Full Text] [Related]
7. Liver tumor-promoting activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in TCDD-sensitive and TCDD-resistant rat strains.
Viluksela M; Bager Y; Tuomisto JT; Scheu G; Unkila M; Pohjanvirta R; Flodström S; Kosma VM; Mäki-Paakkanen J; Vartiainen T; Klimm C; Schramm KW; Wärngård L; Tuomisto J
Cancer Res; 2000 Dec; 60(24):6911-20. PubMed ID: 11156390
[TBL] [Abstract][Full Text] [Related]
8. Quantitative analysis of dose- and time-dependent promotion of four phenotypes of altered hepatic foci by 2,3,7,8-tetrachlorodibenzo-p-dioxin in female Sprague-Dawley rats.
Teeguarden JG; Dragan YP; Singh J; Vaughan J; Xu YH; Goldsworthy T; Pitot HC
Toxicol Sci; 1999 Oct; 51(2):211-23. PubMed ID: 10543023
[TBL] [Abstract][Full Text] [Related]
9. Hepatocarcinogenesis in female Sprague-Dawley rats following discontinuous treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Walker NJ; Tritscher AM; Sills RC; Lucier GW; Portier CJ
Toxicol Sci; 2000 Apr; 54(2):330-7. PubMed ID: 10774815
[TBL] [Abstract][Full Text] [Related]
10. Persistence of TCDD-induced hepatic cell proliferation and growth of enzyme altered foci after chronic exposure followed by cessation of treatment in DEN initiated female rats.
Tritscher AM; Clark GC; Sewall C; Sills RC; Maronpot R; Lucier GW
Carcinogenesis; 1995 Nov; 16(11):2807-11. PubMed ID: 7586202
[TBL] [Abstract][Full Text] [Related]
11. Quantitative evaluation of the promotion by 2,3,7,8-tetrachlorodibenzo-p-dioxin of hepatocarcinogenesis from diethylnitrosamine.
Pitot HC; Goldsworthy T; Campbell HA; Poland A
Cancer Res; 1980 Oct; 40(10):3616-20. PubMed ID: 6108157
[TBL] [Abstract][Full Text] [Related]
12. A method to quantitate the relative initiating and promoting potencies of hepatocarcinogenic agents in their dose-response relationships to altered hepatic foci.
Pitot HC; Goldsworthy TL; Moran S; Kennan W; Glauert HP; Maronpot RR; Campbell HA
Carcinogenesis; 1987 Oct; 8(10):1491-9. PubMed ID: 2888545
[TBL] [Abstract][Full Text] [Related]
13. Dose response for TCDD promotion of hepatocarcinogenesis in rats initiated with DEN: histologic, biochemical, and cell proliferation endpoints.
Maronpot RR; Foley JF; Takahashi K; Goldsworthy T; Clark G; Tritscher A; Portier C; Lucier G
Environ Health Perspect; 1993 Dec; 101(7):634-42. PubMed ID: 8143597
[TBL] [Abstract][Full Text] [Related]
14. TCDD-mediated changes in hepatic epidermal growth factor receptor may be a critical event in the hepatocarcinogenic action of TCDD.
Sewall CH; Lucier GW; Tritscher AM; Clark GC
Carcinogenesis; 1993 Sep; 14(9):1885-93. PubMed ID: 8403215
[TBL] [Abstract][Full Text] [Related]
15. NTP technical report on the toxicology and carcinogenesis studies of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (CAS No. 1746-01-6) in female Harlan Sprague-Dawley rats (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Apr; (521):4-232. PubMed ID: 16835633
[TBL] [Abstract][Full Text] [Related]
16. Modeling the number and size of hepatic focal lesions following exposure to 2,3,7,8-TCDD.
Portier CJ; Sherman CD; Kohn M; Edler L; Kopp-Schneider A; Maronpot RM; Lucier G
Toxicol Appl Pharmacol; 1996 May; 138(1):20-30. PubMed ID: 8658509
[TBL] [Abstract][Full Text] [Related]
17. Modulation of 2,3,7,8-tetrachlorodibenzo-p-dioxin and phenobarbital-induced promotion of hepatocarcinogenesis in rats by the type of diet and vitamin A deficiency.
Flodström S; Busk L; Kronevi T; Ahlborg UG
Fundam Appl Toxicol; 1991 Feb; 16(2):375-91. PubMed ID: 2055368
[TBL] [Abstract][Full Text] [Related]
18. Ovarian tumors in rats induced by chronic 2,3,7,8-tetrachlorodibenzo-p-dioxin treatment.
Davis BJ; Mccurdy EA; Miller BD; Lucier GW; Tritscher AM
Cancer Res; 2000 Oct; 60(19):5414-9. PubMed ID: 11034082
[TBL] [Abstract][Full Text] [Related]
19. Tumor-promoting effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin and phenobarbital in initiated weanling Sprague-Dawley rats: a quantitative, phenotypic, and ras p21 protein study.
Sills RC; Goldsworthy TL; Sleight SD
Toxicol Pathol; 1994; 22(3):270-81. PubMed ID: 7817118
[TBL] [Abstract][Full Text] [Related]
20. Reversible alteration in the expression of the gap junctional protein connexin 32 during tumor promotion in rat liver and its role during cell proliferation.
Neveu MJ; Hully JR; Paul DL; Pitot HC
Cancer Commun; 1990; 2(1):21-31. PubMed ID: 1973356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
